BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25379017)

  • 1. FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression.
    Scheiber MN; Watson PM; Rumboldt T; Stanley C; Wilson RC; Findlay VJ; Anderson PE; Watson DK
    Neoplasia; 2014 Oct; 16(10):801-13. PubMed ID: 25379017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer.
    Song W; Li W; Li L; Zhang S; Yan X; Wen X; Zhang X; Tian H; Li A; Hu JF; Cui J
    Oncotarget; 2015 Sep; 6(27):23764-75. PubMed ID: 26156017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression.
    Feldman RJ; Sementchenko VI; Gayed M; Fraig MM; Watson DK
    Cancer Res; 2003 Aug; 63(15):4626-31. PubMed ID: 12907642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells.
    Tsui KH; Lin YH; Chung LC; Chuang ST; Feng TH; Chiang KC; Chang PL; Yeh CJ; Juang HH
    Cancer Lett; 2016 May; 375(1):142-151. PubMed ID: 26965996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer.
    Turner DP; Moussa O; Sauane M; Fisher PB; Watson DK
    Cancer Res; 2007 Feb; 67(4):1618-25. PubMed ID: 17308102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PDEF is a negative regulator of colon cancer cell growth and migration.
    Moussa O; Turner DP; Feldman RJ; Sementchenko VI; McCarragher BD; Desouki MM; Fraig M; Watson DK
    J Cell Biochem; 2009 Dec; 108(6):1389-98. PubMed ID: 19830706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel role for PDEF in epithelial cell migration and invasion.
    Gunawardane RN; Sgroi DC; Wrobel CN; Koh E; Daley GQ; Brugge JS
    Cancer Res; 2005 Dec; 65(24):11572-80. PubMed ID: 16357167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1.
    Chen N; Zhao G; Yan X; Lv Z; Yin H; Zhang S; Song W; Li X; Li L; Du Z; Jia L; Zhou L; Li W; Hoffman AR; Hu JF; Cui J
    Genome Biol; 2018 Dec; 19(1):218. PubMed ID: 30537986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer.
    Findlay VJ; Turner DP; Moussa O; Watson DK
    Cancer Res; 2008 Oct; 68(20):8499-506. PubMed ID: 18922924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
    Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
    Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.
    Sood AK; Saxena R; Groth J; Desouki MM; Cheewakriangkrai C; Rodabaugh KJ; Kasyapa CS; Geradts J
    Hum Pathol; 2007 Nov; 38(11):1628-38. PubMed ID: 17521701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FLI1 regulates inflammation-associated genes to accelerate leukemogenesis.
    Chen B; Sheng D; Wang C; Liu W; Hu A; Xiao X; Gajendran B; Gao J; Hu J; Sample KM; Zacksenhaus E; Ben-David Y
    Cell Signal; 2022 Apr; 92():110269. PubMed ID: 35104574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
    Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
    Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression.
    Turner DP; Findlay VJ; Kirven AD; Moussa O; Watson DK
    Mol Biol Cell; 2008 Sep; 19(9):3745-57. PubMed ID: 18579687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
    Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
    J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes.
    Nowling TK; Fulton JD; Chike-Harris K; Gilkeson GS
    Mol Immunol; 2008 Jan; 45(1):1-12. PubMed ID: 17606295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
    Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
    Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capsaicin-induced inactivation of sensory neurons promotes a more aggressive gene expression phenotype in breast cancer cells.
    Erin N; Zhao W; Bylander J; Chase G; Clawson G
    Breast Cancer Res Treat; 2006 Oct; 99(3):351-64. PubMed ID: 16583263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Friend leukemia virus integration 1 promotes tumorigenesis of small cell lung cancer cells by activating the miR-17-92 pathway.
    Li L; Song W; Yan X; Li A; Zhang X; Li W; Wen X; Zhou L; Yu D; Hu JF; Cui J
    Oncotarget; 2017 Jun; 8(26):41975-41987. PubMed ID: 28410216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.